Zogenix Risks Fintepla Uptake With Dravet Drug’s High Price

 
• By Mandy Jackson
  
Financial risk assessment / portfolio risk management and protection concept : Businessman holds a white umbrella, protects a dollar bag on basic balance scale, defends money from being cheat or fraud
Fintepla's $96,000 average list price is three times competing drug Epidiolex's cost • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip